Condition: Pancreatic Neuroendocrine Tumor · Sponsor: IRCCS San Raffaele
The goal of this prospective observational study is to generate new personalised 3D preclinical models of pancreatic neuroendocrine tumors. The models will be exploited for studying the mechanisms underlying disease development and progression, as well as for performing drug testing. For the development of the newly proposed models, patients' surgical specimens will be evaluated by the Pathological Unit. If the presence of pathological material in excess, not required for the routine diagnostic procedure, is confirmed, such material will be employed for the generation of the proposed personalised models.
This description comes directly from the study's public registry record.
Massimo Falconi, Professor · 0039 022643 6046 · falconi.massimo@hsr.it
Anna Battistella, MD · 0039 02 26433484 · battistella.anna1@hsr.it
Always discuss trial participation with your own doctor first.
| IRCCS San Raffele Institute | Milan, MI, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06121622